Merck MRK announced that EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting conditional approval to its oral HIF-2α inhibitor, Welireg (belzutifan), for use ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback